701 Research was opened to meet increased demand from Stephens clients to test products for the Asian skin care market. With our turnkey service, we will develop the protocol and study documents, contract and communicate with the testing facility, perform a site initiation, monitor the study, perform the data analysis, write the clinical study report, and manage the entire process.
701 was purchased in 2017 by Toyo Beauty Co., Ltd., one of Japan’s largest cosmetic contract manufacturers, to increase Toyo’s product-testing ability and enable it to enter the US market. 701 moved into a larger facility in March to increase its testing capacity.
Shoichiro Yano, PhD, MD, serves as the Medical Director and an Investigator. He received his MD and PhD in Dermatology from Tokyo University and did his fellowship in Dermatology at New York University.
Dr. Shinichi Watanabe, MD, PhD, was educated at the University of Tokyo and Harvard Medical School. A dermatologist and study Investigator, he also performs visual assessments for certain types of studies.